Swiss Biotech Day 2024

April 22-23, 2024 | Basel, Switzerland

We are excited to announce that we will sponsor, attend, and speak at Swiss Biotech Day, a premier biotechnology conference in Europe that attracts professionals from the global life sciences community.

Be sure to attend our panel “How to Strengthen the Vital Link to Your Investors in Uncertain Times” and connect with our delegates on-site to discover how we can assist you with our agile and holistic biotech solutions.

Events
Category:
Published on:
March 25, 2024

Don’t Miss Our Panel!

How to Strengthen the Vital Link to Your Investors in Uncertain Times

April 23 | 16:00 – 16:45 CET

2023 was a year of uncertainty in the biotech industry. The negative financial environment combined with strong competition for funding resulted in high stress levels not only for those seeking funds, but also for those looking to inject cash in the right companies. This resulted in a disconnect between investors and innovators, placing the entire value creation system at risk.

This panel will focus on practical solutions to restore the vital link between investors and innovators, recognizing their mutual dependence for value creation. Biotech companies prioritize refining their equity story and vision to enhance investor engagement. Investors seek expert guidance to navigate the complexity of opportunities, improving efficiency in investment decisions. The panelists will discuss how we can work together towards a stronger, more sustainable connection between biotech entrepreneurs and investors that helps navigate uncertainties.

Speakers:

  • Alexandra Wollersheim, Partner, Transaction Advisory Services, Alira Health
  • Ajla Hrle, Head of Life Sciences, ATHOS KG
  • Sarah Holland, Chief Business Officer, Cureteq
  • Andrew Kozlov, Managing Director, 4Bio Capital
About Our Speaker
Alexandra-Wollersheim

Alexandra Wollersheim

Partner, Transaction Advisory Services Alexandra Wollersheim is Alira Health’s Partner in the Transaction Advisory group and leads the German operations for Alira Health.

Alexandra has 11 years of experience in the pharmaceutical industry, including her position as a Manager at Staatz Business Development & Strategy, a boutique transaction advisory firm, working on sell- and buy-side M&A and licensing projects. She was also previously Head of Immunology and Critical Care Business Development at Biotest AG.

Her expertise includes strategy, sell- and buy-side M&A, deal structuring, negotiations, and strategic transaction advisory projects with a closed deals in sum above €1B.

Alexandra holds degrees in International Business from the University of Maastricht, Netherlands, and Molecular Biotechnology from the Technical University of Munich, Germany.

Meet Our Delegates

Joris Pezzini

Joris Pezzini

EVP, Biopharma
Ahmad Bechara

Ahmad Bechara

EVP, Pharma
Christian Hughes

Christian Hughes

Senior Manager, Transaction Advisory Services
Marie-Aude Ohresser

Marie-Aude Ohresser

SVP, Regulatory Affairs
Dario Wernet

Dario Wernet

Engagement Manager, Global Market Access

Biotech Resources and Related Content

Biotech Fundraising eu pharma package regulatory changes
Biotech Eliminates Barriers Case Study Complex Innovative Trial Design Article
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.